{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:31:30Z","timestamp":1790361090988,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":112,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005284.pub2","type":"reference-entry","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T01:11:33Z","timestamp":1202260293000},"source":"Crossref","is-referenced-by-count":10,"title":["Treatment for peritoneal dialysis-associated peritonitis"],"prefix":"10.1002","author":[{"given":"Kathryn J","family":"Wiggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/089686089501500214","article-title":"A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD","volume":"15","author":"Anwar","year":"1995","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD005284.pub2-BIB2|cit2","first-page":"234","article-title":"Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis","volume":"8","author":"Merchant","year":"1992","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000184374","article-title":"Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?","volume":"46","author":"Bailie","year":"1987","journal-title":"Nephron"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/089686088700700109","article-title":"A comparison of intraperitoneal and intravenous\/oral antibiotics in CAPD peritonitis","volume":"7","author":"Bennett-Jones","year":"1987","journal-title":"Peritoneal Dial Bulletin"},{"key":"10.1002\/14651858.CD005284.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/26.suppl_F.73","article-title":"A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis","volume":"26 Suppl F","author":"Bennett-Jones","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jac\/16.6.789","article-title":"CAPD peritonitis: A prospective randomized trial of oral versus intraperitoneal treatment with cephradine","volume":"16","author":"Boeschoten","year":"1985","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD005284.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/21.suppl_A.133","article-title":"Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis","volume":"21 Suppl A","author":"Bowley","year":"1988","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0272-6386(88)80224-5","article-title":"Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis - a prospective, randomized comparison of intermittent v continuous therapy","volume":"12","author":"Boyce","year":"1988","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB9|cit9","first-page":"45","article-title":"\"Single dose\" Vancomycin treatment of Continuous Ambulatory Peritoneal Dialysis (CAPD) peritonitis","volume":"7","author":"Munro","year":"1987","journal-title":"Renal Education"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0272-6386(12)80513-0","article-title":"A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis","volume":"15","author":"Chan","year":"1990","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/089686089101100107","article-title":"A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD)","volume":"11","author":"Cheng","year":"1991","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD005284.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1177\/089686089301302S88","article-title":"A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis","volume":"13 Suppl 2","author":"Cheng","year":"1993","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1440-1797.1997.tb00266.x","article-title":"A randomized prospective comparison of oral versus intraperitoneal ofloxacin as the primary treatment of CADP peritonitis","volume":"3","author":"Cheng","year":"1997","journal-title":"Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/089686089801800404","article-title":"A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD","volume":"18","author":"Cheng","year":"1998","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB15|cit15","first-page":"427","article-title":"The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis","volume":"17","author":"Coban","year":"2004","journal-title":"Journal of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/089686080102100509","article-title":"Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)","volume":"21","author":"Fijter","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/089686089101100109","article-title":"Is initial (24 hours) lavage necessary in treatment of CAPD peritonitis?","volume":"11","author":"Ejlersen","year":"1991","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/089686089101100108","article-title":"Initial treatment of dialysis associated peritonitis: A controlled trial of vancomycin versus cefazolin","volume":"11","author":"Flanigan","year":"1991","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD005284.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/26.suppl_F.77","article-title":"A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD)","volume":"26 Suppl F","author":"Friedland","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD005284.pub2-BIB20|cit20","first-page":"233","article-title":"Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients","volume":"16","author":"Gadallah","year":"2000","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD005284.pub2-BIB21|cit21","first-page":"144","article-title":"Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?","volume":"10","author":"Gucek","year":"1994","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD005284.pub2-BIB22|cit22","first-page":"218","article-title":"Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis","volume":"13","author":"Gucek","year":"1997","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"7","key":"10.1002\/14651858.CD005284.pub2-BIB23|cit23","first-page":"797","article-title":"Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial","volume":"9","author":"Innes","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD005284.pub2-BIB24|cit24","series-title":"Nefrolog\u00eda","first-page":"569","article-title":"Initial empiric treatment of peritonitis in CAPD with vancomycin + tobramycin vs. vancomycin + cefotaxime in a CAPD unit","author":"Jim\u00e9nez","year":"1996"},{"issue":"Sept","key":"10.1002\/14651858.CD005284.pub2-BIB25|cit25","first-page":"202A","article-title":"Vancomycin (v) vs cefazolin (c) as initial therapy for peritonitis in peritoneal dialysis (pd) patients [abstract]","volume":"11","author":"Ahmad","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005284.pub2-BIB26|cit26","first-page":"284A","article-title":"Comparison of the efficacy of vancomycin vs cefazolin as initial therapy for peritonitis [abstract]","volume":"9","author":"Khairullah","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/089686080202200307","article-title":"Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients","volume":"22","author":"Khairullah","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/089686080402400508","article-title":"Cefazolin plus ceftazidime versus imipenem\/cilastatin monotherapy for treatment of CAPD peritonitis--a randomized controlled trial","volume":"24","author":"Leung","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/j.1523-1755.2005.00700.x","article-title":"Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function","volume":"68","author":"Lui","year":"2005","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jac\/40.5.729","article-title":"A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: Teicoplanin plus tobramycin versus cephalothin plus tobramycin","volume":"40","author":"Lupo","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD005284.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1177\/089686089301302S87","article-title":"Intraperitoneal vancomycin\/oral pefloxacin versus intraperitoneal vancomycin\/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis","volume":"13 Suppl 2","author":"Lye","year":"1993","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD005284.pub2-BIB32|cit32","first-page":"179","article-title":"A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis","volume":"11","author":"Lye","year":"1995","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD005284.pub2-BIB33|cit33","first-page":"296","article-title":"Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin\/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie","volume":"11","author":"Klaus","year":"1995","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB34|cit34","first-page":"C45","article-title":"Continuous vs intermittent treatment of peritonitis in children on continuous peritoneal dialysis - results of a prospective randomized trial [abstract]","volume":"9","author":"Schaefer","year":"1995","journal-title":"Pedatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1681\/ASN.V101136","article-title":"Intermittent versus continuous intraperitoneal glycopeptide\/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis","volume":"10","author":"Schaefer","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005284.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/26.suppl_F.63","article-title":"A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis","volume":"26 Suppl F","author":"Tapson","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB37|cit37","first-page":"204","article-title":"Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis","volume":"18","author":"Tong","year":"2005","journal-title":"Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB38|cit38","first-page":"154","article-title":"Efficacy of intraperitoneal vancomycin in children on continuous ambulatory peritoneal dialysis: Comparison of intermittent and continuous therapy","volume":"52","author":"Velasquez-Jones","year":"1995","journal-title":"Boletin Medico del Hospital Infantil de Mexico"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005284.pub2-BIB39|cit39","first-page":"S7","article-title":"A prospective randomised trial of teicoplanin plus aztreonam versus cefuroxime in CAPD peritonitis","volume":"1","author":"Wale","year":"1992","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB40|cit40","first-page":"209","article-title":"Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients","volume":"37","author":"Were","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/089686088900900113","article-title":"Tenckhoff catheter replacement or intraperitoneal urokinase: A randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis","volume":"9","author":"Williams","year":"1989","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/ajkd.2001.25205","article-title":"Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis","volume":"38","author":"Wong","year":"2001","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005284.pub2-BIB43|cit43","first-page":"S1","article-title":"Teicoplanin in the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis: a comparative trial against vancomycin","volume":"1","author":"Al-Wali","year":"1992","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/089686089901900320","article-title":"Treatment of CAPD peritonitis with oral trimethoprim\/sulfamethoxazole and intraperitoneal aminoglycoside combination","volume":"19","author":"Celik","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB45|cit45","first-page":"318","article-title":"Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin","volume":"12","author":"Chadwick","year":"1999","journal-title":"Journal of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1994.163","article-title":"Peritoneal dialysis","volume":"45","author":"Chaimovitz","year":"1994","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB47|cit47","first-page":"24","article-title":"Peritonitis during continuous ambulatory peritoneal dialysis. Lavage treatment or not? A prospective study","volume":"4","author":"Groc","year":"1983","journal-title":"Nephrologie"},{"issue":"8552","key":"10.1002\/14651858.CD005284.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(87)90789-6","article-title":"Aztreonam in CAPD peritonitis","volume":"2","author":"Dratwa","year":"1987","journal-title":"Lancet"},{"issue":"8843","key":"10.1002\/14651858.CD005284.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0140-6736(93)90252-C","article-title":"Short-course gentamicin in gram-negative CAPD peritonitis","volume":"341","author":"Dryden","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB50|cit50","first-page":"86","article-title":"UV-flash: clinical evaluation in 97 patients; results of a French multicenter trial","volume":"14","author":"Durand","year":"1994","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/089686089801800216","article-title":"Treatment of CAPD peritonitis with intraperitoneal ampicillin\/sulbactam-aminoglycoside combination","volume":"18","author":"Ersoy","year":"1998","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB52|cit52","first-page":"483","article-title":"Peritonitis in CAPD: Treatment with chlorhexidine","volume":"11","author":"Fabbri","year":"1982","journal-title":"Dialysis & Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB53|cit53","first-page":"391","article-title":"Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis","volume":"48","author":"Goffin","year":"1996","journal-title":"Clinical Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/089686089601600314","article-title":"Combination therapy involving ciprofloxacin for peritonitis","volume":"16","author":"Guest","year":"1996","journal-title":"Peritoneal Dialysis International"},{"issue":"8","key":"10.1002\/14651858.CD005284.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/4.8.759b","article-title":"Treatment of CAPD peritonitis with oral ciprofloxacin","volume":"4","author":"Hancock","year":"1989","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/089686089701700119","article-title":"Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis","volume":"17","author":"Lai","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/089686080302300616","article-title":"Treatment of gram-positive peritonitis in peritoneal dialysis patients: cefazolin or vancomycin?","volume":"23","author":"Levesque","year":"2003","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/089686080002000212","article-title":"Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis","volume":"20","author":"Li","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/089686089701700613","article-title":"Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell","volume":"17","author":"Posthuma","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"8419","key":"10.1002\/14651858.CD005284.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(85)90993-6","article-title":"Extended antibiotic treatment does not prevent early recurrence of CAPD peritonitis","volume":"1","author":"Read","year":"1985","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000441-197109000-00005","article-title":"Trial of oral neomycin during peritoneal dialysis","volume":"262","author":"Sharma","year":"1971","journal-title":"American Journal of the Medical Sciences"},{"issue":"25","key":"10.1002\/14651858.CD005284.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/089686089601600215","article-title":"Comparison of intraperitoneal administration of two preparations of vancomycin in causing chemical peritonitis","volume":"16","author":"Wang","year":"1996","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1681\/ASN.V75811","article-title":"Oral ciprofloxacin for the first-phase treatment of peritonitis associated with continuous ambulatory peritoneal dialysis","volume":"7","author":"Zacherle","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005284.pub2-BIB64|cit64","first-page":"244","article-title":"Higher incidence of catheter-related infections in a tropical climate","volume":"9","author":"Alves","year":"1993","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/089686080002000210","article-title":"The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients","volume":"20","author":"Ates","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/ajkd.2003.50129","article-title":"Empirical aminoglycosides for peritonitis do not affect residual renal function","volume":"41","author":"Baker","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB67|cit67","first-page":"251","article-title":"A new technique of continuous ambulatory peritoneal dialysis (CAPD): double-bag system for freedom to the patient and significant reduction of peritonitis","volume":"13","author":"Bazzato","year":"1980","journal-title":"Clinical Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/089686080302300610","article-title":"Pharmacokinetics of ceftazidime in CAPD-related peritonitis","volume":"23","author":"Booranalertpaisarn","year":"2003","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005284.pub2-BIB69|cit69","first-page":"S91","article-title":"Caring for Australians with Renal Impairment Part 4: Proteinuria, Peritonitis and CMV Infection Guidelines","volume":"9","year":"2005","journal-title":"Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD005284.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3201\/eid0808.010418","article-title":"Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus","volume":"8","author":"Carmeli","year":"2002","journal-title":"Emerging Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB71|cit71","first-page":"635","article-title":"Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy","volume":"34","author":"Carozzi","year":"1988","journal-title":"ASAIO Transactions"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ajkd.2003.08.046","article-title":"Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization","volume":"43","author":"Choi","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/jarr.2000.16268","article-title":"Long-term peritoneal membrane changes","volume":"7","author":"Coles","year":"2000","journal-title":"Advances in Renal Replacement Therapy"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","article-title":"Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis","volume":"11","author":"Davies","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB75|cit75","first-page":"1782","article-title":"The evolution of aminoglycoside therapy: a single daily dose","volume":"53","author":"Deamer","year":"1996","journal-title":"American Family Physician"},{"issue":"6964","key":"10.1002\/14651858.CD005284.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"7109","key":"10.1002\/14651858.CD005284.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/089686080202200308","article-title":"Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen","volume":"22","author":"Fielding","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"10","key":"10.1002\/14651858.CD005284.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1681\/ASN.V7102176","article-title":"Peritonitis influences mortality in peritoneal dialysis patients","volume":"7","author":"Fried","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0272-6386(99)70265-9","article-title":"Pharmacokinetics of intermittent intraperitoneal ceftazidime","volume":"33","author":"Grabe","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1002\/14651858.CD005284.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00467-005-1939-0","article-title":"Twenty years' pediatric chronic peritoneal dialysis in Uruguay: patient and technique survival","volume":"20","author":"Grunberg","year":"2005","journal-title":"Pedatric Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jama.291.6.740","article-title":"Underutilization of peritoneal dialysis","volume":"291","author":"Heaf","year":"2004","journal-title":"JAMA"},{"issue":"7414","key":"10.1002\/14651858.CD005284.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ndt\/16.3.604","article-title":"Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis","volume":"16","author":"Huang","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD005284.pub2-BIB85|cit85","first-page":"117","article-title":"Racial differences and peritonitis in an urban peritoneal dialysis center","volume":"18","author":"Juergensen","year":"2002","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"5","key":"10.1002\/14651858.CD005284.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/089686080302300511","article-title":"A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?","volume":"23","author":"Kan","year":"2003","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD005284.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1177\/089686089901903S03","article-title":"National comparisons: optimal peritoneal dialysis outcomes among Japanese patients","volume":"19 Suppl 3","author":"Kawaguchi","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1797.2005.00413.x","article-title":"Encapsulating peritoneal sclerosis","volume":"10","author":"Kawanishi","year":"2005","journal-title":"Nephrology"},{"key":"10.1002\/14651858.CD005284.pub2-BIB89|cit89","series-title":"Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia)","article-title":"Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE","author":"Lefebvre","year":"1996"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1797.2005.00374.x","article-title":"Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA","volume":"10","author":"Lim","year":"2005","journal-title":"Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/089686089901900111","article-title":"Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients","volume":"19","author":"Manley","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1525-139X.2002.00103.x","article-title":"Treatment of peritonitis in APD: pharmacokinetic principles","volume":"15","author":"Manley","year":"2002","journal-title":"Seminars in Dialysis"},{"key":"10.1002\/14651858.CD005284.pub2-BIB93|cit93","unstructured":"United States Cochrane Center Master list of journals being searched http:\/\/apps1.jhsph.edu\/cochrane\/masterlist.asp"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/089686080402400408","article-title":"Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations","volume":"24","author":"McDonald","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/089686089101100311","article-title":"Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis","volume":"11","author":"Millikin","year":"1991","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1046\/j.1523-1755.1998.00190.x","article-title":"Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group","volume":"54","author":"Monteon","year":"1998","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD005284.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1445-2197.1987.tb01331.x","article-title":"Management of diffuse peritonitis by prolonged postoperative peritoneal lavage","volume":"57","author":"O'Brien","year":"1987","journal-title":"Australian & New Zealand Journal of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/j.ajkd.2004.10.008","article-title":"A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients","volume":"45","author":"Oo","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jac\/dkh138","article-title":"Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis","volume":"53","author":"Oprea","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/089686089401400208","article-title":"Risk factors for peritoneal dialysis-related infections","volume":"14","author":"Oxton","year":"1994","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD005284.pub2-BIB101|cit101","first-page":"180","article-title":"The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis","volume":"17","author":"Passadakis","year":"2001","journal-title":"Advances Peritoneal Dialysis"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB102|cit102","first-page":"62","article-title":"Urokinase: a treatment for relapsing peritonitis due to coagulase-negative staphylococci","volume":"4","author":"Pickering","year":"1989","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/089686080502500203","article-title":"Peritoneal dialysis-related infections recommendations: 2005 Update","volume":"25","author":"Piraino","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ndt\/13.1.154","article-title":"Sclerosing peritonitis: the experience in Australia","volume":"13","author":"Rigby","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/089686080002000411","article-title":"Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition","volume":"20","author":"Shemin","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD005284.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1523-1755.2004.00358.x","article-title":"Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD","volume":"65","author":"Smit","year":"2004","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB107|cit107","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004679.pub2","article-title":"Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients","author":"Strippoli","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/089686080302300611","article-title":"Influence of climate on the incidence of peritoneal dialysis-related peritonitis","volume":"23","author":"Szeto","year":"2003","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD005284.pub2-BIB109|cit109","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1525-139X.2003.16095.x","article-title":"Continuous peritoneal dialysis-associated peritonitis: a review and current concepts","volume":"16","author":"Troidle","year":"2003","journal-title":"Seminars in Dialysis"},{"key":"10.1002\/14651858.CD005284.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-0711-5-6","article-title":"Treatment and outcome of CPD-associated peritonitis","volume":"5","author":"Troidle","year":"2006","journal-title":"Annals of Clinical Microbiology & Antimicrobials"},{"issue":"4","key":"10.1002\/14651858.CD005284.pub2-BIB111|cit111","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/039139880202500402","article-title":"Peritonitis in peritoneal dialysis","volume":"25","author":"Voinescu","year":"2002","journal-title":"International Journal of Artificial Organs"},{"issue":"2","key":"10.1002\/14651858.CD005284.pub2-BIB112|cit112","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005284","article-title":"Treatment for peritoneal dialysis-associated peritonitis. (Protocol)","author":"Wiggins","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005284.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005284.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:34:04Z","timestamp":1630668844000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005284.pub2"}},"subtitle":[],"editor":[{"given":"Kathryn J","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":112,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005284.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005284.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2008,1,23]]}}}